vTv Therapeutics Inc. logo

vTv Therapeutics Inc. (VTVT)

Market Closed
10 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
31. 86
-1.43
-4.2956%
Pre Market
$
35. 49
+3.63 +11.3936%
87.13M Market Cap
- P/E Ratio
- Div Yield
46,139 Volume
0 Eps
$ 33.29
Previous Close
Add Transaction
Day Range
31.85 33
Year Range
18.97 44
Want to track VTVT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

vTv Therapeutics Inc. (VTVT) Statistics

Valuation metrics

Market Cap 87.13M
Enterprise value 641.12K
Trailing P/E (ttm) -303.18
Forward P/E -9.4
PEG ratio 0.28
Price/Sales (ttm) 2.37
Price/Book (mrq) 5.26
Enterprise Value/Revenue 0.02
Enterprise Value/EBITDA -0.1

Overview

Shares outstanding 3.94M
Float 2.4M
Shares short 136.96K
% Held by insiders 0.39%
% Held by institutions 0.38%
Average volume (10 days) 12.1K
Average volume (90 days) 78.87K

Price summary

52-Week low 18.97
52-Week high 44
Beta 0.26
50-Day moving average 31.89
200-Day moving average 35.37

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 21 Nov 2023

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -0.13%
Operating margin -0.25%

Operational effectiveness

Return on assets -0.05%
Return on equity -0.06%

Income Statement

Revenue (ttm) 36.84M
Revenue per share (ttm) 2.97
Quarterly revenue growth (yoy) -
Gross profit (ttm) 12.83M
EBITDA -3.03M
Net income to common (ttm) 2.25M
Diluted EPS (ttm) -0.38
Quarterly earnings growth (yoy) -1%

Balance Sheet

Total cash (mrq) 98.09M
Total cash per share (mrq) 6.98
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 12.48%
Book value per share (mrq) 6.34

Cash Flow

Cash flow statement -10.41M
Levered free cash flow (LFCF) 5.28M